Elektrofi

Elektrofi is a biopharmaceutical formulation technology company revolutionizing biologic therapy delivery. Its Hypercon technology enables convenient at-home subcutaneous self-administration, overcoming limitations of intravenous delivery. This patient-centered approach aims to improve access to life-changing medicines.

Buy Download

Funding Round: Series C

Funding Amount: $112.25M

Date: 31-Oct-2024

Investors: Novo Holdings, RA Capital Management, Royalty Pharma, SR One, TPG Life Sciences Innovations, Eli Lilly and Company, Braidwell LP, BVF, Catalio Capital Management, Checkpoint Capital, Deep Track Capital, General Catalyst, Janus Henderson Investors, Kearny Venture Partners, Logos Capital, Marshall Wace, Paradigm BioCapital, Samsara Biocapital, Woodline Partners LP, an investment fund associated with Leerink Partners

Markets: Biotechnology, Pharmaceuticals, Drug Delivery

HQ: Boston, Massachusetts, United States

Founded: 2016

Website: https://www.elektrofi.com/

LinkedIn: https://www.linkedin.com/company/elektrofi

Twitter: https://twitter.com/elektrofi

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/elektrofi

Pitchbook: https://pitchbook.com/profiles/company/169709-77

Buy Download